Explore
Validate
Learn67140-1-Ig
antibody from Proteintech Group
Targeting: TCF3
bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, VDIR
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67140-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- TCF3 antibody
- Antibody type
- Monoclonal
- Description
- TCF3 antibody (Cat. #67140-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: IF, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1D12E5
- Vial size
- 20ul, 150ul
Submitted references Unexpected Promotion of Bone Regeneration by Inhibition of BMPR1A-Mediated BMP Signalling.
miR-138-5p inhibits WiT-49 cell growth in vitro by downregulating TCF3 expression, and suppresses tumorigenesis in vivo.
TRIM21 promotes colorectal cancer development through regulating DNA replication by TCF3/MCM2/5 axis.
TCF3 activates super-enhancer-driven TRIB2 overexpression to suppress ferroptosis and promote hepatoblastoma proliferation.
Palladin promotes cancer stem cell-like properties in lung cancer by activating Wnt/Β-Catenin signaling.
TCF3 regulates human endometrial stromal cell proliferation and migration in RPL.
Expression of TCF3 in Wilms' tumor and its regulatory role in kidney tumor cell viability, migration and apoptosis in vitro.
Zhou Z, Zhai Y, Liu X, Shao J, Zhou J, Li Z, He J, Lin S, Zhang Q
Cell proliferation 2026 Apr 6;:e70204
Cell proliferation 2026 Apr 6;:e70204
miR-138-5p inhibits WiT-49 cell growth in vitro by downregulating TCF3 expression, and suppresses tumorigenesis in vivo.
Yao Z, Zhou N, Zhang H, Li C, Jiang H, Hao Z, Yan B, Zhao H
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026 Apr 29;
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026 Apr 29;
TRIM21 promotes colorectal cancer development through regulating DNA replication by TCF3/MCM2/5 axis.
Zhang X, Yao H, Hou Y, Zhou K, Liang Y, Hou L, Zhang X, Wang W, Du L, Yao M, Wang J, Meng X
Cell death discovery 2025 Sep 25;11(1):422
Cell death discovery 2025 Sep 25;11(1):422
TCF3 activates super-enhancer-driven TRIB2 overexpression to suppress ferroptosis and promote hepatoblastoma proliferation.
Wu H, Zhu G, Zhu Q, Ma J, Mao S, Ding M, Zhu J, Tang X, Bian Z, Shan Y, Gu S, Sun F, Jiang C, Pan Q
Journal of experimental & clinical cancer research : CR 2025 Dec 29;44(1):329
Journal of experimental & clinical cancer research : CR 2025 Dec 29;44(1):329
Palladin promotes cancer stem cell-like properties in lung cancer by activating Wnt/Β-Catenin signaling.
Shu X, Chen M, Liu SY, Yu L, Sun LX, Sun LC, Ran YL
Cancer medicine 2023 Feb;12(4):4510-4520
Cancer medicine 2023 Feb;12(4):4510-4520
TCF3 regulates human endometrial stromal cell proliferation and migration in RPL.
Wei XW, Liu XQ, Zhang YC, Qin CM, Lin Y, Tian FJ
Reproduction (Cambridge, England) 2022 Mar 29;163(5):281-291
Reproduction (Cambridge, England) 2022 Mar 29;163(5):281-291
Expression of TCF3 in Wilms' tumor and its regulatory role in kidney tumor cell viability, migration and apoptosis in vitro.
Zhou N, Yan B, Ma J, Jiang H, Li L, Tang H, Ji F, Yao Z
Molecular medicine reports 2021 Sep;24(3)
Molecular medicine reports 2021 Sep;24(3)
No comments: Submit comment
No validations: Submit validation data